Luvo Reviews
50% off your first 4 weeks - semaglutide from $104.50, tirzepatide from $124.50
Last updated: Oct 25, 2026
Reviewed for medical accuracy by Francheska Capistrano, RMT, MPH · · How we review
Reviewed for medical accuracy by Francheska Capistrano, RMT, MPH · Medical Content Reviewer
Medically reviewed Reviewed · Written by Treatments Hub Research Team · How we review
We may earn a commission from links on this page - it never affects our rankings (how we stay objective).
The bottom line
Luvo's offer is clear and its inclusions are generous: one price covers the medication, the clinician, the check-ins and the shipping, and there is no membership fee or contract. The first four weeks are inexpensive.
The decision should be made on the second-delivery price - $209 for semaglutide, $249 for tirzepatide, $259 for tablets, billed every four weeks - which is a mid-to-upper price for compounded GLP-1s next to the $41-$149 plans on our comparison. If a cheap trial month, a tablet option or a cancel-anytime structure matters more than the lowest ongoing price, Luvo is a reasonable choice; confirm shipping times and the dispensing pharmacy at checkout, and check back for a review record as the brand builds one.
Luvo products & prices
Published prices with their conditions - the whole card links to the provider.
Luvo is a telehealth weight-loss provider that sells compounded semaglutide and tirzepatide as weekly injections, compounded semaglutide as a daily tablet, and brand-name Ozempic, each after an online clinician review. Its pricing is built around one offer and one cadence: 50% off the first four weeks, then a fixed price every four weeks from the second delivery, with the medication, the clinician review, ongoing support and check-ins and discreet shipping all inside that price and no separate membership fee.
The first-month figures are among the lower entry prices we track; the ongoing prices sit in the mid-to-upper range for compounded GLP-1s, so the honest comparison is the second-delivery number, not the launch offer. Luvo does not yet have a Trustpilot profile, so what follows is built from its published pricing and terms rather than a review record.
Key Features
- Compounded semaglutide injection: $104.50 for the first 4 weeks, then $209 every 4 weeks
- Compounded tirzepatide injection: $124.50 for the first 4 weeks, then $249 every 4 weeks
- Compounded semaglutide tablets (daily): $129.50 for the first 4 weeks, then $259 every 4 weeks
- Brand-name Ozempic: $1,299 per 4 weeks of injections
- Medication, clinician review, ongoing support and check-ins and discreet shipping included; no membership fees; cancel anytime
Treatment Options
- Compounded semaglutide (GLP-1) weekly injection
- Compounded tirzepatide (GLP-1 + GIP) weekly injection
- Compounded semaglutide daily tablet
- Brand-name Ozempic (semaglutide) pen
Pricing
Semaglutide injection
Then $209 every 4 weeksCompounded semaglutide (GLP-1) weekly injection
- 50% off the first 4 weeks (regular $209)
- Medication, clinician review, check-ins and shipping included
- No membership fees; cancel anytime
Tirzepatide injection
Then $249 every 4 weeksCompounded tirzepatide (GLP-1 + GIP) weekly injection
- 50% off the first 4 weeks (regular $249)
- Medication, clinician review, check-ins and shipping included
- No membership fees; cancel anytime
Semaglutide tablets
Then $259 every 4 weeksCompounded semaglutide daily tablet
- 50% off the first 4 weeks (regular $259)
- One tablet a day, no injection
- No membership fees; cancel anytime
Ozempic
Delivered every 4 weeksBrand-name Ozempic (semaglutide) pen
- FDA-approved brand-name pen
- Clinician review, check-ins and shipping included
- Cancel anytime
Luvo prices by four-week delivery, not by calendar month. Compounded semaglutide injections are $104.50 for the first four weeks (50% off the regular $209) and $209 every four weeks from the second delivery; compounded tirzepatide is $124.50 and then $249; compounded semaglutide tablets are $129.50 and then $259; brand-name Ozempic is $1,299 per four weeks.
Every price includes the medication, the clinician review, ongoing support and check-ins and discreet shipping, and Luvo states there are no membership fees and that you can cancel anytime. Because a four-week cycle repeats 13 times a year, the ongoing prices work out to roughly $226 (semaglutide), $270 (tirzepatide) and $281 (tablets) per calendar month - our arithmetic, shown so the comparison with monthly-billed providers is fair.
Prices read from Luvo's product pages on October 25, 2026; the provider's site is the live source.
What we verified
Checked September 2026
Every line below was checked against Luvo's own published pricing and plan information - not copied from other review sites. When we can't verify something, we leave it out rather than guess.
- Semaglutide price
- $104.50 for the first 4 weeks, then $209 every 4 weeks
- Tirzepatide price
- $124.50 for the first 4 weeks, then $249 every 4 weeks
- Semaglutide tablets
- $129.50 for the first 4 weeks, then $259 every 4 weeks
- Brand-name Ozempic
- $1,299 per 4 weeks
- Membership fee
- None
- Commitment
- None - cancel anytime
- Trustpilot record
- No profile yet
How Luvo Works
- 1
Choose a treatment and complete the online intake
Pick the injection, tablet or brand-name option and answer the health questions.
- 2
A clinician reviews your plan
Dosing is individualized and adjusted over time for response and tolerability; medication is shipped only if prescribed.
- 3Every 4 weeks
Receive your medication
Four weeks of medication per delivery, shipped discreetly, with ongoing support and check-ins included.
Pros
- Low first-month entry: 50% off the first four weeks on every compounded option
- One all-in price - medication, clinician review, check-ins and shipping - with no membership fee
- Three compounded formats (two injections and a daily tablet) plus brand-name Ozempic from one provider
- Cancel anytime, stated on every product page
- Dosing described as individualized and adjusted over time by the clinician
Cons
- Ongoing prices ($209-$259 every 4 weeks) are above most compounded plans we track once the first-month offer ends
- Billing every 4 weeks means 13 charges a year, not 12
- No Trustpilot profile yet, so no independent review record to check
- Shipping times and the pharmacy that fills the prescription are not stated on the pages we captured - ask before paying
Who It's Best For
- People who want a low-cost first month to find out how they tolerate a GLP-1
- Anyone who prefers a daily semaglutide tablet to a weekly injection
- Buyers who want compounded and brand-name options from the same provider
Final Verdict
Luvo's offer is clear and its inclusions are generous: one price covers the medication, the clinician, the check-ins and the shipping, and there is no membership fee or contract. The first four weeks are inexpensive.
The decision should be made on the second-delivery price - $209 for semaglutide, $249 for tirzepatide, $259 for tablets, billed every four weeks - which is a mid-to-upper price for compounded GLP-1s next to the $41-$149 plans on our comparison. If a cheap trial month, a tablet option or a cancel-anytime structure matters more than the lowest ongoing price, Luvo is a reasonable choice; confirm shipping times and the dispensing pharmacy at checkout, and check back for a review record as the brand builds one.
Luvo Review: FAQs
Is Luvo legit?
Luvo is a telehealth weight-loss provider that sells compounded semaglutide and tirzepatide as weekly injections, compounded semaglutide as a daily tablet, and brand-name Ozempic, each after an online clinician review. Its pricing is built around one offer and one cadence: 50% off the first four weeks, then a fixed price every four weeks from the second delivery, with the medication, the clinician review, ongoing support and check-ins and discreet shipping all inside that price and no separate membership fee. The first-month figures are among the lower entry prices we track; the ongoing prices sit in the mid-to-upper range for compounded GLP-1s, so the honest comparison is the second-delivery number, not the launch offer. Luvo does not yet have a Trustpilot profile, so what follows is built from its published pricing and terms rather than a review record.
How much does Luvo cost?
Luvo prices by four-week delivery, not by calendar month. Compounded semaglutide injections are $104.50 for the first four weeks (50% off the regular $209) and $209 every four weeks from the second delivery; compounded tirzepatide is $124.50 and then $249; compounded semaglutide tablets are $129.50 and then $259; brand-name Ozempic is $1,299 per four weeks. Every price includes the medication, the clinician review, ongoing support and check-ins and discreet shipping, and Luvo states there are no membership fees and that you can cancel anytime. Because a four-week cycle repeats 13 times a year, the ongoing prices work out to roughly $226 (semaglutide), $270 (tirzepatide) and $281 (tablets) per calendar month - our arithmetic, shown so the comparison with monthly-billed providers is fair. Prices read from Luvo's product pages on October 25, 2026; the provider's site is the live source.
What treatments does Luvo offer?
Luvo offers Compounded semaglutide (GLP-1) weekly injection, Compounded tirzepatide (GLP-1 + GIP) weekly injection, Compounded semaglutide daily tablet, Brand-name Ozempic (semaglutide) pen.
Who is Luvo best for?
Luvo is best for People who want a low-cost first month to find out how they tolerate a GLP-1; Anyone who prefers a daily semaglutide tablet to a weekly injection; Buyers who want compounded and brand-name options from the same provider.
Is Luvo worth it?
Luvo's offer is clear and its inclusions are generous: one price covers the medication, the clinician, the check-ins and the shipping, and there is no membership fee or contract. The first four weeks are inexpensive. The decision should be made on the second-delivery price - $209 for semaglutide, $249 for tirzepatide, $259 for tablets, billed every four weeks - which is a mid-to-upper price for compounded GLP-1s next to the $41-$149 plans on our comparison. If a cheap trial month, a tablet option or a cancel-anytime structure matters more than the lowest ongoing price, Luvo is a reasonable choice; confirm shipping times and the dispensing pharmacy at checkout, and check back for a review record as the brand builds one.
Not sure if Luvo is right for you?
Take our free quiz and get a personalized provider recommendation.
Find Your MatchRelated
Guides
Sources & methodology
We built this review of Luvo from the provider'sown published pricing, plans and policies, cross-checked against regulatory and peer-reviewed medical references, and read alongside real customer feedback. Prices and plan details were verified against the provider's published information; we do not take providers' word for their own claims without checking.
Provider information
Pricing, plans, shipping and policies, checked against each provider's own site.
- Luvo - pricing, plans & policies as published on its own site
Provider data checked September 2026
Customer & community feedback
Third-party signals shown on this page and in our full reviews: verified Trustpilot ratings, public Reddit discussions, and independent YouTube reviews. We report what these sources say - we never fold their ratings into our own scores.
Medical & regulatory references
- 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
- 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
- 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
- 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
- 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
- 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
- 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)
Last reviewed September 2026. We revisit comparisons when providers change their pricing or policies. This page is information only and is not medical advice - always consult a licensed clinician before starting treatment.
Medical disclaimer
This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.
Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.
Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.
Sources & medical references
Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.
- 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
- 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
- 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
- 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
- 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
- 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
- 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)